A blood test measuring phosphorylated tau protein (p-tau217) can predict Alzheimer’s disease up to 20 years before symptoms appear with about 90-96% accuracy, matching the performance of more invasive tests like cerebrospinal fluid analysis and brain imaging. This advance offers a practical, less invasive tool for early detection, enabling individuals to take preventive measures and Read more…
September 23, 2025 8:37 am PT by Jose Rossello, MD, PhD, MHCM - 0 comments